Sonoma Pharmaceuticals, Inc. (SNOA)

NASDAQ: SNOA · Real-Time Price · USD

1.340

0.00 (0.00%)

At close: Aug 24, 2026, 4:00 PM EDT

1.350

+0.010 (0.75%)

After-hours: Aug 24, 2026, 7:34 PM EDT

Sonoma Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	21.92	19.53	14.29	12.74	13.27	12.63
Revenue Growth	47.00%	36.68%	12.20%	-4.05%	5.10%	-32.21%
Cost of Revenue	13.39	12.11	8.82	7.99	8.8	8.64
Gross Profit	8.53	7.42	5.47	4.75	4.48	3.99
Selling, General & Admin	7.66	7.61	7.36	7.58	8.84	9.76
Research & Development	2.27	2.27	1.81	1.87	0.21	0.13
Operating Expenses	9.93	9.88	9.18	9.45	9.05	9.88
Operating Income	-1.41	-2.46	-3.71	-4.7	-4.57	-5.89
Interest Expense	-	-	-	-	-	-0.01
Currency Exchange Gain (Loss)	1.3	1.45	0.24	-0.83	-0.69	-0.58
Other Non Operating Income (Expenses)	-2.4	-2.4	0.56	0.5	0.08	0.19
EBT Excluding Unusual Items	-2.51	-3.42	-2.91	-5.03	-5.18	-6.29
Gain (Loss) on Sale of Assets	-	-	-	-	-	0.15
Other Unusual Items	-	-	-	-	-	0.72
Pretax Income	-2.51	-3.42	-2.91	-5.03	-5.18	-5.42
Income Tax Expense	-0.24	-0.24	0.55	-0.2	-0.03	-0.33
Earnings From Continuing Operations	-2.26	-3.18	-3.46	-4.84	-5.15	-5.09
Net Income	-2.26	-3.18	-3.46	-4.84	-5.15	-5.09
Net Income to Common	-2.26	-3.18	-3.46	-4.84	-5.15	-5.09
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	2	2	1	0	0	0
Shares Outstanding (Diluted)	2	2	1	0	0	0
Shares Change	55.39%	35.70%	172.75%	168.12%	27.93%	32.92%
EPS (Basic)	-1.01	-1.89	-2.79	-10.63	-30.35	-38.34
EPS (Diluted)	-1.01	-1.89	-2.79	-10.63	-30.35	-38.34
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Free Cash Flow	-2.66	-4.13	-0.17	-2.4	-6.42	-4.39
Free Cash Flow Per Share	-1.19	-2.45	-0.14	-5.28	-37.84	-33.06
Gross Margin	38.91%	37.97%	38.25%	37.26%	33.73%	31.62%
Operating Margin	-6.41%	-12.60%	-25.97%	-36.91%	-34.43%	-46.62%
Profit Margin	-10.33%	-16.26%	-24.20%	-37.97%	-38.81%	-40.28%
Free Cash Flow Margin	-12.11%	-21.12%	-1.18%	-18.85%	-48.38%	-34.72%
EBITDA	-1.27	-2.32	-3.57	-4.53	-4.45	-5.7
EBITDA Margin	-5.80%	-11.89%	-25.00%	-35.53%	-33.49%	-45.15%
D&A For EBITDA	0.14	0.14	0.14	0.18	0.13	0.19
EBIT	-1.41	-2.46	-3.71	-4.7	-4.57	-5.89
EBIT Margin	-6.41%	-12.60%	-25.97%	-36.91%	-34.43%	-46.62%
Advertising Expenses	-	0.09	0.19	0.16	0.16	0.09

SEC Filings: 10-K · 10-Q